Crossmark

Technological innovation of HoLEP: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

Crossref DOI link: https://doi.org/10.1007/s00345-024-05438-8

Published Online: 2025-01-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gao, Zhixiang

Wang, Ping

Liu, Haiyong

Ding, Yue

Xu, Li

Sun, Zhiwei

Du, Renji

Gu, Lijuan

Shen, Yajun

Wang, Rong
Funding

Funding for this research was provided by:

Major Science and Technology projects of Changzhou Health Committee (ZD202034)
License Information

Text and Data Mining valid from 2025-01-10

Version of Record valid from 2025-01-10
More Information

Article History

Received: 5 June 2024

Accepted: 31 December 2024

First Online: 10 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below